AAAAAA

   
Results: 1-7 |
Results: 7
Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone
Authors: Desikan, KR Tricot, G Munshi, NC Anaissie, E Spoon, D Fassas, A Toor, A Zangari, M Badros, A Morris, C Vesole, DH Siegel, D Jagannath, S Barlogie, B
Citation: Kr. Desikan et al., Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone, BR J HAEM, 112(1), 2001, pp. 242-247
Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 studyof 169 patients
Authors: Barlogie, B Desikan, R Eddlemon, P Spencer, T Zeldis, J Munshi, N Badros, A Zangari, M Anaissie, E Epstein, J Shaughnessy, J Ayers, D Spoon, D Tricot, G
Citation: B. Barlogie et al., Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 studyof 169 patients, BLOOD, 98(2), 2001, pp. 492-494
Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone
Authors: Desikan, KR Tricot, G Dhodapkar, M Fassas, A Siegel, D Vesole, DH Jagannath, S Singhal, S Mehta, J Spoon, D Anaissie, E Barlogie, B Munshi, N
Citation: Kr. Desikan et al., Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone, BONE MAR TR, 25(5), 2000, pp. 483-487
Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities
Authors: Desikan, R Barlogie, D Sawyer, J Ayers, D Tricot, G Badros, A Zangari, M Munshi, NC Anaissle, E Spoon, D Siegel, D Jagannath, S Vesole, D Epstein, J Shaughnessy, J Fassas, A Lim, S Roberson, P Crowley, J
Citation: R. Desikan et al., Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities, BLOOD, 95(12), 2000, pp. 4008-4010
Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapy
Authors: Singhal, S Mehta, J Desikan, K Siegel, D Singh, J Munshi, N Spoon, D Anaissie, E Ayers, D Barlogie, B
Citation: S. Singhal et al., Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapy, BONE MAR TR, 24(1), 1999, pp. 13-17
Age is not a prognostic variable with autotransplants for multiple myeloma
Authors: Siegel, DS Desikan, KR Mehta, J Singhal, S Fassas, A Munshi, N Anaissie, E Naucke, S Ayers, D Spoon, D Vesole, D Tricot, G Barlogie, B
Citation: Ds. Siegel et al., Age is not a prognostic variable with autotransplants for multiple myeloma, BLOOD, 93(1), 1999, pp. 51-54
Total therapy with tandem transplants for newly diagnosed multiple myeloma
Authors: Barlogie, B Jagannath, S Desikan, KR Mattox, S Vesole, D Siegel, D Tricot, G Munshi, N Fassas, A Singhal, S Mehta, J Anaissie, E Dhodapkar, D Naucke, S Cromer, J Sawyer, J Epstein, J Spoon, D Ayers, D Cheson, B Crowley, J
Citation: B. Barlogie et al., Total therapy with tandem transplants for newly diagnosed multiple myeloma, BLOOD, 93(1), 1999, pp. 55-65
Risultati: 1-7 |